Aude Robert

6PUBLICATIONS
15CO-AUTHORS
Molecular targetsAboriginal and Torres Strait Islander mothers and babies health and wellbeingBiologically active moleculesApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|May 15, 2024
Impairing hydrolase transport machinery prevents human melanoma metastasis.

Alice Nordlinger, Justine Del Rio, Shivang Parikh

|Oct 22, 2021
Shiga Toxins as Antitumor Tools.

Aude Robert, Joëlle Wiels

|Mar 05, 2021
Drimane Derivatives as the First Examples of Covalent BH3 Mimetics that Target MCL-1.

Florian Daressy, Florian Malard, Line Seguy

|Jul 06, 2020
The BCL-2 family protein inhibitor ABT-737 as an additional tool for the treatment of EBV-associated post-transplant lymphoproliferative disorders.

Aude Robert, Anaïs Pujals, Loetitia Favre

|Nov 24, 2019
Correction: Transient stabilization, rather than inhibition, of MYC amplifies extrinsic apoptosis and therapeutic responses in refractory B-cell lymphoma.

Colleen T Harrington, Elena Sotillo, Aude Robert

|Mar 28, 2019
Transient stabilization, rather than inhibition, of MYC amplifies extrinsic apoptosis and therapeutic responses in refractory B-cell lymphoma.

Colleen T Harrington, Elena Sotillo, Aude Robert

Pageof 1

Frequent Collaborators

3 joint publications

Joëlle Wiels

2 joint publications

Katharina E Hayer

2 joint publications

Deanne Taylor

2 joint publications

Andrei Thomas-Tikhonenko